brazil is making strides to build a bio-based pmma market in the country. poly(methyl methacrylate) (pmma) has traditionally been produced from fossil fuels, providing a significant environmental challenge. to address this, brazil has provided significant incentives and funding for the development of the bio pmma market in the country. recently, braskem, a petrochemical giant in brazil, has announced plans to become the world’s first petrochemical giant to produce the raw material from sugar cane. this feedstock shift is expected to lead to the production of hundreds of kilos of bio-based pmma from bio-based raw materials. this move is also expected to reduce the carbon footprint of the brazilian polymeric industry, strengthening the country's global position as a leader in green chemicals. in addition, brazil’s public institutions, such as the brazilian agricultural research corporation (embrapa) and the brazilian development bank (bndes), have been actively promoting and funding the development of bio pmma projects and the country's green chemistry sector. this public funding for bio-based pmma has aimed to develop the necessary technology and infrastructure to align with the country's policies on renewable energy sources and environmental conservation. furthermore, brazil’s leading research universities have also been engaging in collaborations with bio-based pmma companies to develop green technologies. through the advancement of the country's green chemistry sector, brazil is expected to establish itself as a reliable and sustainable supplier of bio pmma to the global market. in summary, brazil’s presence in the bio-based pmma market is expected to increase in the coming years. the country’s substantial investment in developing green technologies, public funding and collaboration with leading research institutions in the industry are all contributing to the growth of the market. as the country is able to produce more of the raw material from nontraditional sources, brazil is expected to become a significant player in the bio-based pmma market.
